These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 937114)

  • 1. The biochemical defect in Farber's disease.
    Dulaney J; Moser HW; Sidbury J; Milunsky A
    Adv Exp Med Biol; 1976; 68():403-11. PubMed ID: 937114
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
    Chen WW; Decker GL
    Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of Farber's disease--histochemical, electron microscopic and biochemical studies].
    Hamanaka S; Hara A; Otsuka F
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):629-34. PubMed ID: 1920894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.
    Samuelsson K; Zetterström R
    Scand J Clin Lab Invest; 1971 Jun; 27(4):393-405. PubMed ID: 5109101
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.
    Sugita M; Connolly P; Dulaney JT; Moser HW
    Lipids; 1973 Jul; 8(7):401-6. PubMed ID: 4740649
    [No Abstract]   [Full Text] [Related]  

  • 6. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease.
    Sugita M; Iwamori M; Evans J; McCluer RH; Dulaney JT; Moser HW
    J Lipid Res; 1974 May; 15(3):223-6. PubMed ID: 4363967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farber's disease (lysosomal acid ceramidase deficiency).
    Jameson RA; Holt PJ; Keen JH
    Ann Rheum Dis; 1987 Jul; 46(7):559-61. PubMed ID: 3662645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular lesions of Farber's disease and their experimental reproduction in tissue culture.
    Rutsaert J; Tondeur M; Vamos-Hurwitz E; Dustin P
    Lab Invest; 1977 May; 36(5):474-80. PubMed ID: 194109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtle clues to diagnosis of skin diseases by electron microscopy. "Farber bodies" in disseminated lipogranulomatosis (Farber's disease).
    Schmoeckel C
    Am J Dermatopathol; 1980; 2(2):153-6. PubMed ID: 7246981
    [No Abstract]   [Full Text] [Related]  

  • 10. Farber's disease.
    Singhi PD; Padmini P; Mantri SB
    Indian Pediatr; 1991 Nov; 28(11):1338-41. PubMed ID: 1808062
    [No Abstract]   [Full Text] [Related]  

  • 11. Wolman's disease with hypolipoproteinemia and acanthocytosis: clinical and biochemical observations.
    Eto Y; Kitagawa T
    J Pediatr; 1970 Nov; 77(5):862-7. PubMed ID: 5504079
    [No Abstract]   [Full Text] [Related]  

  • 12. Farber's disease as a ceramidosis: clinical, radiological and biochemical aspects.
    Toppet M; Vamos-Hurwitz E; Jonniaux G; Cremer N; Tondeur M; Pelc S
    Acta Paediatr Scand; 1978 Jan; 67(1):113-9. PubMed ID: 626064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anesthetic implications of a patient with Farber's lipogranulomatosis.
    Asada A; Tatekawa S; Terai T; Hayashi M; Hatano M; Ikeshita K; Fujimori M
    Anesthesiology; 1994 Jan; 80(1):206-9. PubMed ID: 8291711
    [No Abstract]   [Full Text] [Related]  

  • 14. [Farber's lipogranulomatosis].
    Koga M
    Nihon Rinsho; 1995 Dec; 53(12):3009-13. PubMed ID: 8577050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts.
    Dulaney JT; Milunsky A; Sidbury JB; Hobolth N; Moser HW
    J Pediatr; 1976 Jul; 89(1):59-61. PubMed ID: 932904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography.
    Iwamori M; Moser HW
    Clin Chem; 1975 May; 21(6):725-9. PubMed ID: 1122616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramidase deficiency in Farber's disease (lipogranulomatosis).
    Sugita M; Dulaney JT; Moser HW
    Science; 1972 Dec; 178(4065):1100-2. PubMed ID: 4678225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.
    Pavone L; Moser HW; Mollica F; Reitano C; Durand P
    Johns Hopkins Med J; 1980 Nov; 147(5):193-6. PubMed ID: 7441940
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid studies in Wolman's disease.
    Kyriakides EC; Filippone N; Paul B; Grattan W; Balint JA
    Pediatrics; 1970 Sep; 46(3):431-6. PubMed ID: 5468779
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disseminated lipogranulomatosis (Farber disease) with hydrops fetalis].
    Schäfer A; Harzer K; Kattner E; Schäfer HJ; Stoltenburg G; Lietz H
    Pathologe; 1996 Mar; 17(2):145-9. PubMed ID: 8650144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.